Skip to main content
SpringerLink
Log in

Japan MHLW updates tolvaptan hepatic dysfunction warnings

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. See also this issue p40; 803092760 and 803092744

Reference

  • Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare. Tolvaptan and Hepatic Dysfunction. Pharmaceuticals and Medical Devices Safety Information : 5-8, No. 303, Jul 2013. Available from: URL: http://www.pmda.go.jp

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Japan MHLW updates tolvaptan hepatic dysfunction warnings. Reactions Weekly 1469, 3 (2013). https://doi.org/10.1007/s40278-013-5743-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-5743-5

Search

Navigation